NSEAgreements2 Sept 2026 · 2 Sept 2026, 07:18 pm
Agreements
Coromandel International Limited · COROMANDEL
✦ AI SummaryRelated Party
Coromandel International Limited has informed the Exchange about an agreement for conversion of loan to equity with Coromandel Chemicals Limited, a wholly owned subsidiary, at an issue price of Rs. 39.95 per equity share.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern5/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Coromandel International Limited has informed the Exchange about Agreements
Attachments (1)
📄pdf
Download →
COROMANDELINT_02092026191508_CIL_SELetter_Sep_2026_SD.pdf
View document text
Coromandel International Limited
Corporate Office: Olympia Terraces,
15B SP, SIDCO Industrial Estate, Guindy,
Chennai – 600032, Tamil Nadu, India
CIN: L24120TG1961PLC000892
Tel: 91-44-42525300
E-mail: mail@coromandel.murugappa.com
Website: www.coromandel.biz
Ref. No.: 2026-27/037 September 2, 2026
National Stock Exchange of India Limited BSE Limited,
Exchange Plaza, 5th Floor, Phiroze Jeejeebhoy Towers,
Bandra-Kurla Complex, Dalal Street,
Bandra (E), Mumbai 400 051 Mumbai 400 001.
Symbol: COROMANDEL S c r i p C o d e : 5 0 6 3 9 5
Dear Sirs/Madam,
Sub : Disclosure under Regulation 30 of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended
("SEBI Listing Regulations")
In furtherance to our letter ref no. 2026-27/026 dated July 23, 2026 and pursuant to Regulation 30
and other applicable provisions of the SEBI Listing Regulations, we wish to inform that the Company
had executed an agreement for conversion with the Coromandel Chemicals Limited for conversion of
loan including accrued interest amounting to Rs. 108.07 Crores to equity shares of face value of Rs.
10/- each of Coromandel Chemicals Limited, a wholly owned subsidiary of the Company, at an issue
price of Rs. 39.95/- per equity share (including premium).
The details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 read with the SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated
January 30, 2026 are enclosed as Annexure A.
We request you to acknowledge and take it on your record.
Thanking you,
Yours truly,
For Coromandel International Limited
B Shanmugasundaram
Company Secretary & Compliance officer
Enclosure: As Above.
Coromandel International Limited
Corporate Office: Olympia Terraces,
15B SP, SIDCO Industrial Estate, Guindy,
Chennai – 600032, Tamil Nadu, India
CIN: L24120TG1961PLC000892
Tel: 91-44-42525300
E-mail: mail@coromandel.murugappa.com
Website: www.coromandel.biz
Disclosure pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations 2015
Name(s) of parties with whom the Coromandel International Limited and
agreement is entered; Coromandel Chemicals Limited (Wholly Owned
subsidiary
The Company proposes to convert the loan
Purpose of entering into the agreement including accrued interest amount of Rs. 108.07
Crores into equity vide Agreement for conversion
agreement dated September 2, 2026
Size of agreement Rs. 108.07 Crores
Shareholding, if any, in the entity with The company owns 100% shareholding in
whom the agreement is executed. Coromandel Chemicals Limited
Significant terms of the agreement (in Conversion of Loan to Equity
brief) special rights like right to appoint
directors, first right to share subscription
in case of issuance of shares, right to
restrict any change in capital structure
etc.
Whether the said parties are related to Yes, Coromandel Chemicals Limited is a wholly
promoter/promoter group/ group owned subsidiary of the Company
companies in any manner. If yes, nature
of relationship
Whether the transaction would fall Yes, The Company at its Audit Committee and
within related party transactions? If yes, Board Meeting held on July 23, 2026 approved the
whether the same is done at “arm’s said related party transaction. The Transaction is
length undertaken on an arm’s length basis
In case of issuance of shares to the 2,70,52,132 Equity shares of face value of Rs. 10/-
parties, details of issue price, class of each of Coromandel Chemicals Limited, a wholly
shares issued owned subsidiary of the Company, at an issue price
of Rs. 39.95/- per equity share (including premium,
if any) is issued equivalent to Rs. 108.07 Crores
In case of loan agreements, details of S.No. Particulars Details
lender/borrower, nature of the loan, 1 Lender Coromandel
total amount of loan granted/taken, International
total amount outstanding, date of Limited
execution of the loan 2 Borrower Coromandel
agreement/sanction letter, details of Chemicals
the security provided to the lenders / by Limited
the borrowers for such loan or in case 3 Nature of Loan Unsecured
outstanding loans lent to a party or loan
Coromandel International Limited
Corporate Office: Olympia Terraces,
15B SP, SIDCO Industrial Estate, Guindy,
Chennai – 600032, Tamil Nadu, India
CIN: L24120TG1961PLC000892
Tel: 91-44-42525300
E-mail: mail@coromandel.murugappa.com
borrowed from a party become material 4 Date of exW ee cb us tit ie o: n w ww.cor 1omst an Dd ee cl. ebi mz ber
on a cumulative basis; 2025
5 Security provided, if Nil
6 Amount of Loan Rs. 108.07
outstanding as on Crore
date of disclosure (Amount of
Loan
outstanding
including
accrued
interest as on
30th June,
2026)
Any other disclosures related to such No nominee director has been appointed through
agreements, viz., details of nominee on proposed agreement. No conflict of interest arises
the board of directors of the listed other than the related party relationship disclosed
entity, potential conflict of interest above.
arising out of such agreements, etc.;
In case of termination or amendment of Not Applicable
agreement, listed entity shall disclose
additional details to the stock
exchange(s):
i. name of parties to the agreement;
ii. nature of the agreement;
iii. date of execution of the agreement;
iv. details of amendment and impact
thereof or reasons of termination and
impact thereof.